SASMAR PHARMACEUTICALS
Board
1 director, last change in 2024Director (not named in the articles), permanent representative MANCINI John-Michael
appointed by deed of 28-05-2024
term without a fixed end
earlier manager, until 28-05-2024
also on the board of 1 other company
Permanent representatives 1
MANCINI John-Michael
Permanent representative, for MANCINI HOLDINGS PTY LIMITED
appointed by deed of 28-05-2024
Mandates through the years
1 name, the dashed line is todayMANCINI HOLDINGS PTY LIMITED
Director (not named in the articles)
Director (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
- MANCINI HOLDINGS PTY LIMITED
- Director (not named in the articles), appointed by deed of 28-05-2024, still in office
- Manager, until 28-05-2024
Control
Consolidating parent
consolidates
This company
SASMAR PHARMACEUTICALS
Equity €379,779
Profit €133,640 in 2025
Capital
- Contribution
- €18,600
- Shares
- 100,000
- Contribution per share
- €0.19
- Equity per share
- €3.80 in 2025
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- Mancini Holdings PTY LTD
Source: shareholder structure in its own accounts, parent in its own accounts
Articles of association
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 16-04-2025 (in French)
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Monday of June at 11:00deed of 28-05-2024 (in French)
Shareholders
2 ownersOwners 2
- Mancini Holdings PTY LTDparentSourceown accounts 201699.99%
- Mancini Holdings PTY LTDconsolidating parentconsolidates
Capital transactions
Capital over time
- 16-04-2025 Capital stated in the deed · 100,000 shares
- 28-05-2024 Converted to unavailable equity
- 28-05-2024 Converted to available equity